RESUMO
A 1299 bp full length cDNA encoding Teladorsagia circumcincta enolase (TeciENO) was cloned, expressed in Escherichia coli and the recombinant protein purified and its kinetic properties determined. Helminth enolase sequences were used to construct a phylogenetic tree. The predicted protein consisted of 433 amino acids and was present as a single band of about 50 kDa on SDS-PAGE. Multiple alignments of the protein sequence of TeciENO with homologues from other helminths showed 98% similarity with Haemonchus contortus enolase, 78-95% similarity to other nematode sequences and 72-75% similarity to cestode and trematode enolases. Substrate binding sites and conserved regions were identified and were completely conserved in other homologues. The optimum pH for TeciENO activity at 25 °C was pH 7, the Km for 2-phophoglycerate 0.09 ± 0.04 mM and the Vmax was 604 ± 6 nmol min-1 mg-1 protein (both mean ± SD, n = 2). TeciENO activity was inhibited by 11.5% by 1 mM citrate (p < 0.001). Antibodies in both serum and saliva from field-immune, but not nematode-naïve, sheep recognised recombinant TeciENO in enzyme-linked immunosorbent assays. The recognition of the recombinant protein by antibodies generated by exposure of sheep to native enolase indicates similar antigenicity of the two proteins.
Assuntos
Anticorpos Anti-Helmínticos/imunologia , Fosfopiruvato Hidratase/imunologia , Fosfopiruvato Hidratase/metabolismo , Trichostrongyloidea/enzimologia , Trichostrongyloidea/imunologia , Tricostrongiloidíase/veterinária , Abomaso/parasitologia , Sequência de Aminoácidos , Animais , Anticorpos Anti-Helmínticos/sangue , Clonagem Molecular , DNA Complementar , DNA de Helmintos/genética , Ensaio de Imunoadsorção Enzimática , Proteínas de Helminto/química , Proteínas de Helminto/genética , Proteínas de Helminto/imunologia , Proteínas de Helminto/metabolismo , Concentração de Íons de Hidrogênio , Cinética , Fosfopiruvato Hidratase/química , Fosfopiruvato Hidratase/genética , Filogenia , Proteínas Recombinantes , Saliva/imunologia , Ovinos , Doenças dos Ovinos/imunologia , Tricostrongiloidíase/imunologia , Tricostrongiloidíase/parasitologiaRESUMO
BACKGROUND: Hepatocellular carcinoma-associated antigen 59 (HCA59) from excretory/secretory products of Haemonchus contortus is known to have the ability to modulate the functions of host cells. However, its immunogenicities using different nanoparticles adjuvants remain poorly understood. PURPOSE: The study aimed to select an efficient nanoparticle antigen delivery system, which could enhance the immune responses of Haemonchus contortus HCA59 in mice. METHODS: Here, the immune responses induced by the recombinant protein of HCA59 (rHCA59) with poly-D,L-lactide-co-glycolide (PLGA) nanoparticles, Chitosan nanoparticles, mixture of PLGA and Chitosan nanoparticles (rHCA59-Chitosan-PLGA), and Freund's complete adjuvant were observed, respectively, in mice. Cytokine and antibody levels induced by different groups were detected by ELISA assay. The effects of lymphocyte proliferations on different groups were examined using CCK-8 kit. Phenotypes of T cells and dendritic cells were analyzed by flow cytometry. RESULTS: On day 14 post vaccination, levels of IgM, IgG1, IgG2a, IFN-γ, IL-4, and IL-17 were significantly increased in the groups immunized with rHCA59 encapsulated with nanoparticles. After mice were vaccinated with rHCA59 loaded with Chitosan/PLGA nanoparticles, lymphocytes proliferated significantly. Additionally, the percentages of CD4+ T cells (CD3+ CD4+), CD8+ T cells (CD3+ CD8+), and dendritic cells (CD11c+ CD83+, CD11c+ CD86+) were obviously up-regulated in the mice immunized with nanoparticles, especially in the rHCA59-Chitosan-PLGA antigen delivery system group. CONCLUSION: The findings of this research demonstrated that rHCA59-Chitosan-PLGA antigen delivery system could induce higher immune responses in mice model and indicated that rHCA59 might be a good candidate molecule to develop nanovaccines against Haemonchus contortus in future study.
Assuntos
Adjuvantes Imunológicos/administração & dosagem , Antígenos Glicosídicos Associados a Tumores/imunologia , Quitosana/química , Proteínas de Helminto/imunologia , Nanopartículas/administração & dosagem , Copolímero de Ácido Poliláctico e Ácido Poliglicólico/química , Linfócitos T/imunologia , Animais , Proliferação de Células , Citocinas/metabolismo , Feminino , Haemonchus/metabolismo , Ativação Linfocitária , Camundongos , Camundongos Endogâmicos ICR , Nanopartículas/química , Linfócitos T/efeitos dos fármacos , VacinaçãoRESUMO
Schistosomiasis threatens 800 million people worldwide. Chronic pathology manifests as hepatosplenomegaly, and intestinal schistosomiasis caused by Schistosoma mansoni can lead to liver fibrosis, cirrhosis, and blood in the stool. To assist the only FDA-approved drug, praziquantel, in parasite elimination, the development of a vaccine would be of high value. S. mansoni Cathepsin B (SmCB) is a well-documented vaccine target for intestinal schistosomiasis. Herein, we test the increased efficacy and immunogenicity of SmCB when combined with sulfated lactosyl archaeol (SLA) archaeosomes or AddaVax™ (a squalene based oil-in-water emulsion). Both vaccine formulations resulted in robust humoral and cell mediated immune responses. Impressively, both formulations were able to reduce parasite burden greater than 40% (WHO standard), with AddaVax™ reaching 86.8%. Additionally, SmCB with both adjuvants were able to reduce granuloma size and the amount of larval parasite hatched from feces, which would reduce transmission. Our data support SmCB as a target for S. mansoni vaccination; especially when used in an adjuvanted formulation.
Assuntos
Adjuvantes Imunológicos/farmacologia , Antígenos Arqueais/farmacologia , Catepsina B/farmacologia , Proteínas de Helminto/farmacologia , Lipídeos/farmacologia , Polissorbatos/farmacologia , Schistosoma mansoni/imunologia , Esquistossomose mansoni/prevenção & controle , Esqualeno/farmacologia , Vacinas Sintéticas/farmacologia , Animais , Anticorpos/sangue , Catepsina B/imunologia , Células Cultivadas , Citocinas/metabolismo , Composição de Medicamentos , Feminino , Proteínas de Helminto/imunologia , Imunidade Celular/efeitos dos fármacos , Imunidade Humoral/efeitos dos fármacos , Imunização , Imunogenicidade da Vacina , Camundongos Endogâmicos C57BL , Contagem de Ovos de Parasitas , Schistosoma mansoni/enzimologia , Esquistossomose mansoni/imunologia , Esquistossomose mansoni/parasitologia , Caramujos , Vacinas Sintéticas/imunologiaRESUMO
Anthelmintic activity of benzimidazole carbamate anthelmintics is low against dormant Toxocara canis larvae during late infections in paratenic hosts. The present study was conducted to examine the efficacy of pure fenbendazole, or drug incorporated into sterically stabilized liposomes (SL-FBZ) administered to T. canis-infected mice alone and after its co-administration with the immunomodulator (1-->3)-beta-D-glucan against larvae localized in muscles and brains. Therapy with either drug forms (in total 250 mg/kg in 10 doses) commenced on day 28 post-infection (p.i.) and the efficacy of treatment, examined on day 30 after the last dose of drug, was the highest in groups of mice treated with SL-FBZ in combination with glucan (89.5+/-5.8% in the muscles, 66.1+/-8.1% in brains). During 56 days of follow-up after termination of therapy, serum levels of anti-TES IgG antibodies, circulating IgG-TES immune complexes (CIC) as well as IgG antibodies to the most immunogenic part of recombinant myosin antigen of T. canis larvae were investigated. In contrast to anti-TES IgG antibodies, levels of CIC and anti-myosin antibodies were in the linear correlation with the efficacy of treatments beginning from day 38 post-therapy. We also showed that the serum levels of CIC as well as anti-myosin IgG antibodies seem to be the suitable serological markers for the monitoring of progress in larval destruction and TES resorption from the tissues.
Assuntos
Fenbendazol/uso terapêutico , Glucanos/uso terapêutico , Toxocara canis/imunologia , Toxocaríase/tratamento farmacológico , Animais , Anticorpos Anti-Helmínticos/sangue , Western Blotting , Encéfalo/efeitos dos fármacos , Encéfalo/parasitologia , Quimioterapia Combinada , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática , Fenbendazol/química , Glucanos/química , Proteínas de Helminto/imunologia , Imunoglobulina G/sangue , Fatores Imunológicos/química , Fatores Imunológicos/uso terapêutico , Larva/efeitos dos fármacos , Larva/imunologia , Lipossomos/química , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Músculos/efeitos dos fármacos , Músculos/parasitologia , Miosinas/imunologia , Toxocaríase/imunologia , Toxocaríase/parasitologia , Resultado do TratamentoRESUMO
A cDNA encoding a secretory cellulose-binding protein was cloned from the root-knot nematode (Meloidogyne incognita) with RNA fingerprinting. The putative full-length cDNA, named Mi-cpb-1, encoded a 203 amino acid protein containing an N-terminal secretion signal peptide. The C-terminal sequence of the putative MI-CBP-1 was similar to a bacterial-type cellulose-binding domain, whereas the N-terminal sequence did not show significant similarity to any proteins in data bases. Recombinant MI-CBP-1 lacked cellulase activity, but bound to cellulose and plant cell walls. In Southern blot hybridization, Mi-cbp-1 hybridized with genomic DNA from M. incognita, M. arenaria, and M. javanica, but not M. hapla, Heterodera glycines, or Caenorhabditis elegans. Polyclonal antibodies raised against recombinant MI-CBP-1 strongly labeled secretory granules in subventral gland cells of second-stage juveniles in indirect immunofluorescence microscopy. Enzyme-linked immunosorbent assay detection of MI-CBP-1 in stylet secretions of second-stage juveniles with the polyclonal antibodies indicated MI-CBP-1 could be secreted through the nematodes' stylet, suggesting that the cellulose-binding protein may have a role in pathogenesis.
Assuntos
Proteínas de Transporte/genética , Celulose/metabolismo , DNA de Helmintos/genética , Proteínas de Helminto/genética , Tylenchoidea/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Proteínas de Transporte/imunologia , Proteínas de Transporte/metabolismo , Clonagem Molecular , Primers do DNA/genética , DNA Complementar/genética , Técnica Indireta de Fluorescência para Anticorpo , Glucana 1,4-beta-Glucosidase , Proteínas de Helminto/imunologia , Proteínas de Helminto/metabolismo , Dados de Sequência Molecular , Raízes de Plantas/parasitologia , Homologia de Sequência de Aminoácidos , Tylenchoidea/metabolismo , Tylenchoidea/patogenicidade , beta-Glucosidase/metabolismoRESUMO
Adults worms of Strongyloides venezuelensis were cultured in vitro. After overnight incubation, about 60% of the worms adhered firmly to the bottom of culture vessels by secreting adhesive substances from the mouth. A single worm produced 24.5 +/- 10.1 of the adhesion spots overnight. When they were transferred to new culture vessels, they still produced new spots comparable to those produced for first 24 hr. The adhesion spots were positively stained with Coomassie brilliant blue and also with mucicarmine, periodic acid-Schiff, and alcian blue, pH 2.5, but not with alcian blue, pH 0.3, indicating their glycoprotein nature. The substances were amorphous and did not contain cells or nuclei. Histologic staining with a panel of lectins showed that the adhesive substances were rich in mannose, N-acetyl galactosamine, and N-acetyl glucosamine, but devoid of sialic acid. These characteristics were distinct from those of jejunal goblet cell mucins of rats. Adhesive substances contained antigenic components recognized by sera from infected rats. Thus, the adhesive substances secreted from the mouth of S. venezuelensis were clearly of parasite origin. We consider the production/secretion of the adhesive substances by S. venezuelensis adult worms a key step for the parasites to invade and establish the host epithelial layer.
Assuntos
Antígenos de Helmintos/metabolismo , Glicoproteínas/metabolismo , Proteínas de Helminto/metabolismo , Strongyloides/metabolismo , Adesividade , Animais , Anticorpos Anti-Helmínticos/biossíntese , Antígenos de Helmintos/química , Antígenos de Helmintos/imunologia , Vidro , Glicoproteínas/química , Glicoproteínas/imunologia , Proteínas de Helminto/química , Proteínas de Helminto/imunologia , Soros Imunes/imunologia , Masculino , Plásticos , Ratos , Ratos WistarRESUMO
Soluble adult worm antigens (SWAP) of Schistosoma mansoni were fractionated by fast protein liquid chromatography (FPLC) system, using Q-Sepharose anion-exchange resin, in order to characterize antigenic fractions that may elicit cell responses in human schistosomiasis. SWAP fractions were eluted by 20 nM Tris-HCl solution (pH 9.6) with an increasing gradient of 1 M NaCl. The FPLC system was able to resolve 6 fractions, enumerated I to VI, according to the NaCl gradient. The analysis of each fraction on SDS-PAGE showed that fractions I to IV were constituted by multiple protein bands with M, ranging from 21 to > 200 kDa. Large amounts of nucleic acids were evidenced in fractions V and VI, as revealed by ethidium bromide staining of agarose electrophoresis gels. Using ELISA, it was shown that sera from chronic schistosomiasis patients contained antibodies that recognized antigens in practically all fractions. Studies were designed to investigate the capacity of these fractions to induce cell proliferation and granuloma formation. It was demonstrated that fraction III stimulated significant proliferative response of peripheral blood mononuclear cells (PBMC) from chronic schistosomiasis patients. However, fraction III coupled to polyacrylamide beads induced small granuloma formation in vitro, whereas beads coated with fractions I, II and V were able to induce significant granuloma reactions.
Assuntos
Antígenos de Helmintos/imunologia , Granuloma/imunologia , Leucócitos Mononucleares/imunologia , Schistosoma mansoni/imunologia , Esquistossomose mansoni/imunologia , Resinas Acrílicas , Animais , Anticorpos Anti-Helmínticos/imunologia , Antígenos de Helmintos/química , Antígenos de Helmintos/isolamento & purificação , Divisão Celular , Fracionamento Celular , Células Cultivadas , Proteínas de Helminto/análise , Proteínas de Helminto/química , Proteínas de Helminto/imunologia , Humanos , Soros Imunes , Microesferas , Peso Molecular , Ácidos Nucleicos/análiseRESUMO
The major challenge in the development of anti-schistosome vaccines is to use defined antigens to stimulate an appropriate immune response that leads to resistance. Several promising candidate vaccine antigens including the glycolytic enzyme triose-phosphate isomerase (SmTPI), a 28 kDa glutathione-S-transferase (Sm28), the myofibrilar protein paramyosin (Sm97), an integral membrane protein (Sm23) and calpain (Smcalpain) have been characterised and their primary sequences derived for Schistosoma mansoni. Furthermore, sequences are available for synthetic peptides mimicking epitopes on these molecules capable of inducing schistosome-specific T- and B-cell responses. These schistosome vaccine candidates have generally been tested with varying degrees of success as single components, with only one report of the use of a multivalent antigen or multi-epitope approach. We describe the assembly of multiple defined and different epitopes of S. mansoni into a variety of single covalent structures; these included a DNA vaccine encoding different epitopes in tandem, the polyprotein itself that is encoded by this DNA and branched synthetic peptide epitope-based polymers in which the individual epitopes are pendant from an inert backbone. Each of the vaccine constructs examined, with the exception of the DNA vaccine, generated antibodies that were capable of binding to a tandem sequence of the epitopes. Although these results were encouraging, none of the constructs protected animals from subsequent challenge infection, indicating that the immune responses elicited were inadequate or inappropriate for parasite killing in vivo.
Assuntos
DNA de Helmintos/administração & dosagem , Proteínas de Helminto/administração & dosagem , Schistosoma mansoni/imunologia , Esquistossomose mansoni/prevenção & controle , Vacinas/administração & dosagem , Animais , Anticorpos Anti-Helmínticos/sangue , Anticorpos Anti-Helmínticos/imunologia , DNA de Helmintos/imunologia , Epitopos , Feminino , Proteínas de Helminto/imunologia , Imunoglobulina G/sangue , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Plasmídeos/genética , Polímeros/administração & dosagem , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/isolamento & purificação , Schistosoma mansoni/genética , Esquistossomose mansoni/imunologia , Vacinas/imunologiaRESUMO
Echinococcus multilocularis is a cestode parasite that predominantly infects red and arctic foxes as definitive hosts. Ingestion of E. multilocularis eggs and subsequent post-oncospheral infection with the larval stage (metacestode) of the parasite results in alveolar echinococcosis (AE), a life-threatening hepatic disease concerning humans and other intermediate hosts such as small rodents. The primary fluid-filled vesicles of the asexually proliferating metacestode are comprised of an inner germinal layer, a syncytial tegument, and an outer, acellular, so-called laminated layer. This laminated layer may play an important role in protecting the developing E. multilocularis metacestode from host immune reactions, and laminated layer-associated components represent potential targets for intervention during the course of AE. We have used an in vitro cultivation technique for the long-term maintenance and proliferation of E. multilocularis metacestodes in order to generate premature (protoscolex-free) parasite vesicles. A polyclonal antiserum was raised against this host-free parasite tissue. Subsequent immunoblot analysis of parasite fractions obtained by Triton X-114 extraction lead to the identification of a 116 kDa protein (named EmP2) within the Triton-insoluble fraction. The characterization of EmP2 by SDS-PAGE, Western blotting, and by immunofluorescence revealed that EmP2 is a laminated layer-associated protein.
Assuntos
Antígenos de Helmintos/análise , Echinococcus/imunologia , Proteínas de Helminto/análise , Animais , Anticorpos Anti-Helmínticos/imunologia , Anticorpos Anti-Helmínticos/isolamento & purificação , Afinidade de Anticorpos , Antígenos de Helmintos/imunologia , Antígenos de Helmintos/isolamento & purificação , Equinococose/parasitologia , Echinococcus/crescimento & desenvolvimento , Técnica Indireta de Fluorescência para Anticorpo , Proteínas de Helminto/imunologia , Proteínas de Helminto/isolamento & purificação , Interações Hospedeiro-Parasita , Imuno-Histoquímica , Larva/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Octoxinol , PolietilenoglicóisRESUMO
The recombinant Schistosoma mansoni 62 kDa myosin fragment, rIrV-5, is highly protective in experimental animals, however, vaccination of mice and rats with the recombinant Schistosoma japonicum homologue, rSj62, did not induce significant resistance against S. japonicum infection. To explore alternative ways of presenting this antigen, we further constructed a plasmid (VRSj62) which encodes Sj62 using the VR1020 vector and tested it in vaccination experiments. Four immunisations with 10 microg VRSj62 DNA alone were sufficient to induce high and progressively increasing levels of IgG antibodies against rSj62 with increasing numbers of injections in CBA/Ca mice (IgG titre > or =1:25000), and three injections with 50 microg VRSj62 DNA alone induced significant IgG responses in C57Bl/6 mice (IgG titre, 1:1600). However, vaccination with plasmid DNA entrapped in cationic liposomes or together with pUC19 DNA as a source of CpG motifs, both of which have been reported to enhance immune responses, did not enhance specific antibody production. In spite of the stimulation of specific antibodies against rSj62 with the naked DNA construct no resistance to challenge was demonstrated.
Assuntos
Antígenos de Helmintos/imunologia , DNA Recombinante/genética , Proteínas de Helminto/imunologia , Miosinas/imunologia , Plasmídeos/genética , Schistosoma japonicum/imunologia , Vacinas de DNA/imunologia , Animais , Anticorpos Anti-Helmínticos/biossíntese , Anticorpos Anti-Helmínticos/imunologia , Reações Antígeno-Anticorpo , Antígenos de Helmintos/genética , Ilhas de CpG , Feminino , Proteínas de Helminto/administração & dosagem , Proteínas de Helminto/genética , Imunização Secundária , Imunoglobulina G/biossíntese , Imunoglobulina G/imunologia , Lipossomos/administração & dosagem , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Microscopia Imunoeletrônica , Músculos/imunologia , Músculos/ultraestrutura , Miosinas/genética , Schistosoma japonicum/genética , Schistosoma japonicum/ultraestrutura , Esquistossomose Japônica/prevenção & controle , Vacinação , Vacinas de DNA/administração & dosagemRESUMO
Alveolar and cystic hydatidosis are caused by infection with the larval stages of Echinococcus multilocularis and Echinococcus granulosus, respectively. A host-protective antigen has been identified in E. granulosus. Here we identify the presence of a closely related protein in E. multilocularis, characterize and express a cDNA encoding the antigen (designated EM95), determine the structure of the em95 gene, and demonstrate that the EM95 recombinant protein can be used to induce significant levels of protection against challenge infection with E. multilocularis eggs in mice.